Videos
Advanced Ovarian Cancer
HER2+ BC: Residual Disease After Neoadjuvant Therapy
Bassel El-Rayes, MD, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer.
Early HER2+ Breast Cancer
Multiple Myeloma
Noopur Raje, MD, discusses the current treatment options for patients diagnosed with multiple myeloma. At this time, a number of FDA-approved drugs and different combinations are available.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
The Gap Between What Oncologists Have Been Prescribing and What the ROS1 Data Now Supports
2
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient Prostate Cancer
3
Talquetamab Plus Daratumumab Improves PFS vs SOC in R/R Multiple Myeloma
4
FDA Accepts BLA for Ozekibart in Unresectable or Metastatic Chondrosarcoma
5